Status

Active, not recruiting clinical trials

Studies whose latest retrieved public registry status is Active, not recruiting.

664active studies

0recruiting now

65countries represented

1,498largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Active, not recruitingPhase 3

A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)

Obesity, Overweight and/or ObesityCondition

PF-08653944, PlaceboTreatment

Argentina, Bulgaria188 locations

PfizerSponsor

Updated 2026-09-08 · NCT07400653See eligibility →

Active, not recruitingNot applicable

Maternal Obesity, Breast Milk Composition, and Infant Growth

Obesity, PregnancyCondition

Intervention not listedTreatment

United States2 locations

University of MinnesotaSponsor

Updated 2026-09-08 · NCT03301753See eligibility →

Active, not recruitingNot applicable

Effects of Blueberry on Gut Microbiota and Metabolic Syndrome

Gut Microbiota, Metabolic SyndromeCondition

50 g of blueberry powder, taken daily for 8 weeks, 50g of placebo blueberry powder, taken daily for 8 weeksTreatment

Canada1 locations

Laval UniversitySponsor

Updated 2026-09-08 · NCT03266055See eligibility →

Active, not recruitingNot applicable

Effect of Raspberry on Gut Microbiota and Metabolic Syndrome

Gut Microbiota, Metabolic SyndromeCondition

Raspberry supplementTreatment

Canada1 locations

Laval UniversitySponsor

Updated 2026-09-08 · NCT03620617See eligibility →

Active, not recruitingNot applicable

Evaluation of a Comprehensive School Nutrition Enrichment Intervention (CSNEI) in Rural School Districts

Obesity, Childhood, Nutrition, HealthyCondition

CSNEITreatment

United States1 locations

University of ArkansasSponsor

Updated 2026-09-08 · NCT05507866See eligibility →

Active, not recruitingPhase 3

Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

Non-alcoholic SteatohepatitisCondition

Semaglutide, PlaceboTreatment

Argentina, Australia558 locations

Novo Nordisk A/SSponsor

Updated 2026-09-04 · NCT04822181See eligibility →

Active, not recruitingPhase 3

Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity

Obesity and OverweightCondition

MET097, PlaceboTreatment

Bulgaria, Canada169 locations

PfizerSponsor

Updated 2026-09-04 · NCT07311850See eligibility →

Active, not recruitingPhase 3

Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide

Overweight, ObesityCondition

Cagrilintide, Placebo (matched to Cagrilintide)Treatment

Argentina, Canada67 locations

Novo Nordisk A/SSponsor

Updated 2026-09-04 · NCT07220759See eligibility →

Active, not recruitingPhase 2

Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss

Obesity & Overweight, Mobility DisabilityCondition

Enobosarm, Semaglutide (Wegovy) weekly injectionTreatment

United States13 locations

Veru Inc.Sponsor

Updated 2026-09-04 · NCT07446998See eligibility →

Active, not recruitingNot applicable

Water Intake and Weight Control in Older Adults

Overweight and ObesityCondition

Water intake and weight control in older adults - Premeal Water + hypocaloric diet, Water intake and weight control in older adults - Total Daily Water + hypocaloric dietTreatment

United States1 locations

Virginia Polytechnic Institute and State UniversitySponsor

Updated 2026-09-04 · NCT05843318See eligibility →

Active, not recruitingPhase 2

Phase 2 Study of MWN109 Tablet for Weight-Loss Maintenance in Participants With Overweight or Obesity

Overweight , ObesityCondition

MWN109 1, MWN109 2Treatment

China1 locations

Shanghai Minwei Biotechnology Co., LtdSponsor

Updated 2026-09-04 · NCT07804797See eligibility →

Active, not recruitingNot applicable

Screening Adults With Obesity to Reduce Heart Failure Events

Obesity, Heart FailureCondition

Screening for heart failureTreatment

Netherlands1 locations

Franciscus GasthuisSponsor

Updated 2026-09-03 · NCT06137261See eligibility →

Active, not recruitingPhase 4

Bariatric Surgery vs. Semaglutide vs. Tirzepatide

Obesity and Obesity-related Medical ConditionsCondition

Bariatric Surgery, SemaglutideTreatment

United States1 locations

Ali AminianSponsor

Updated 2026-09-03 · NCT06803888See eligibility →

Active, not recruitingNot applicable

Behavioral Weight Loss and Sleep Health Intervention

Overweight and Obese AdultsCondition

BWL+SleepTreatment

United States1 locations

University of Colorado, DenverSponsor

Updated 2026-09-03 · NCT07255287See eligibility →

Active, not recruitingNot applicable

HomeGrown: A Family-based Lifestyle Intervention to Support Healthy Development of Young Children With Down Syndrome

Down Syndrome, Child ObesityCondition

The HomeGrown, WaitlistTreatment

United States1 locations

UNC Lineberger Comprehensive Cancer CenterSponsor

Updated 2026-09-03 · NCT07296861See eligibility →

Active, not recruitingNot applicable

BfedBwell INSPIRE Pilot

Cancer Survivorship, Overweight , ObesityCondition

BfedBwell - Core Curriculum, BfedBwell - 1:1 CounselingTreatment

United States1 locations

University of Colorado, DenverSponsor

Updated 2026-09-03 · NCT07446595See eligibility →

Active, not recruitingNot applicable

Longitudinal Changes in Spinopelvic Alignment and Sagittal Balance After Bariatric Surgery in Patients With Morbid Obesity: A Prospective Observational Study

Obesity, Spine ConditionCondition

Intervention not listedTreatment

Turkey (Türkiye)1 locations

Marmara UniversitySponsor

Updated 2026-09-03 · NCT07794553See eligibility →

Active, not recruitingNot applicable

Longitudinal Changes in Lower Extremity Alignment and Mechanical Axis Parameters After Bariatric Surgery in Patients With Morbid Obesity: A Prospective Observational Study

Obese, Limb DeformitiesCondition

Obese.Treatment

Turkey (Türkiye)1 locations

Marmara UniversitySponsor

Updated 2026-09-03 · NCT07794566See eligibility →

Active, not recruitingPhase 3

Breast Cancer WEight Loss Study (BWEL Study)

Breast Ductal Carcinoma In Situ, Invasive Breast CarcinomaCondition

Health Education Program, Weight Loss InterventionTreatment

Canada, Guam1,498 locations

Alliance for Clinical Trials in OncologySponsor

Updated 2026-09-02 · NCT02750826See eligibility →

Active, not recruitingPhase 1

A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver

ObesityCondition

BI 456906, SemaglutideTreatment

Netherlands1 locations

Boehringer IngelheimSponsor

Updated 2026-09-02 · NCT05202353See eligibility →

Active, not recruitingNot applicable

Time Restricted Eating to Mitigate Obesity in Veterans With Spinal Cord Injury

Spinal Cord Injury, ObesityCondition

Time Restricted EatingTreatment

United States1 locations

VA Office of Research and DevelopmentSponsor

Updated 2026-09-02 · NCT05921487See eligibility →

Active, not recruitingPhase 2

Semaglutide Therapy for Alcohol Reduction (STAR)

Addiction, Alcohol Use DisorderCondition

Take Control, SemaglutideTreatment

United States1 locations

National Institute on Drug Abuse (NIDA)Sponsor

Updated 2026-09-02 · NCT06015893See eligibility →

Active, not recruitingNot applicable

Addressing Social Determinants of Health in Child Obesity Treatment Using Community Health Workers

Child Obesity, Social Determinants of HealthCondition

Community Health Worker, Child weight management interventionTreatment

United States1 locations

Children's Mercy Hospital Kansas CitySponsor

Updated 2026-09-02 · NCT06520657See eligibility →

Active, not recruitingPhase 2

A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation

ObesityCondition

Trevogrumab-Part A, Trevogrumab-Part B and Part CTreatment

Puerto Rico, United States60 locations

Regeneron PharmaceuticalsSponsor

Updated 2026-09-01 · NCT06299098See eligibility →

Active, not recruitingNot applicable

4:3 Intermittent Fasting Intervention in Adults With Breast Cancer and Overweight or Obesity

Breast CancerCondition

Weight LossTreatment

United States2 locations

University of Colorado, DenverSponsor

Updated 2026-09-01 · NCT06399276See eligibility →

Active, not recruitingPhase 2

Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment

Electric Stimulation Therapy, ObesityCondition

Transcranial Direct Current Stimulation (TDCS), Sham/no-stimulationTreatment

United States1 locations

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Sponsor

Updated 2026-09-01 · NCT00739362See eligibility →

Active, not recruitingNot applicable

Effect of Weight Loss on Urinary Oxalate Excretion in Obese Calcium Oxalate Kidney Stone Formers

Kidney StoneCondition

Low Oxalate Diet before Weight Loss, Oral load of oxalate and sucralose before Weight LossTreatment

United States1 locations

University of Alabama at BirminghamSponsor

Updated 2026-09-01 · NCT04633811See eligibility →

Active, not recruitingNot applicable

Telenutrition for Individuals With SCI

Spinal Cord Injuries, ObesityCondition

TelenutritionTreatment

United States1 locations

Santa Clara Valley Health & Hospital SystemSponsor

Updated 2026-09-01 · NCT05468437See eligibility →

Active, not recruitingNot applicable

The Effect of Acupuncture on Sarcopenia and Obesity in Patients With Sarcopenic Obesity.

Sarcopenic Obesity, Acupuncture TreatmentCondition

Diet and exercise, AcupunctureTreatment

Turkey (Türkiye)1 locations

Ayşe Ukbe BaykutSponsor

Updated 2026-09-01 · NCT07797140See eligibility →

Active, not recruitingPhase 3

REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels

Cardiovascular DiseaseCondition

Cagrilintide, SemaglutideTreatment

Argentina, Australia633 locations

Novo Nordisk A/SSponsor

Updated 2026-08-31 · NCT05669755See eligibility →

Active, not recruitingPhase 3

A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight

ObesityCondition

Cagrilintide, SemaglutideTreatment

Argentina, Australia256 locations

Novo Nordisk A/SSponsor

Updated 2026-08-31 · NCT05567796See eligibility →

Active, not recruitingNot applicable

The PIVOT Trial: Project on EHR-Integrated Lifestyle Interventions for Adults Aged Fifty and Older

CARDIOMETABOLIC CONDITIONS, ObesityCondition

Base intervention, Augmented InterventionTreatment

United States3 locations

University of Illinois at ChicagoSponsor

Updated 2026-08-31 · NCT05654142See eligibility →

Active, not recruitingNot applicable

Pulses Consumption and Its Role in Managing Systemic Inflammation, Insulin Sensitivity and Gut Microbiome in Human

Insulin Sensitivity, Overweight or ObesityCondition

Control, Black beanTreatment

United States1 locations

Clinical Nutrition Research Center, Illinois Institute of TechnologySponsor

Updated 2026-08-28 · NCT04267705See eligibility →

Active, not recruitingNot applicable

Long-term Health and Economic Effects of an Individualized Lifestyle Intervention (LI-PAD-Extended)

Overweight, ObesityCondition

Individualized physical activity and dietTreatment

Sweden1 locations

Vastra Gotaland RegionSponsor

Updated 2026-08-28 · NCT07605169See eligibility →

Active, not recruitingPhase 2

Phase 2 Study to Evaluate the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants With Overweight

Overweight , ObesityCondition

MWN109 1, MWN109 2Treatment

China1 locations

Shanghai Minwei Biotechnology Co., LtdSponsor

Updated 2026-08-28 · NCT07791537See eligibility →

Active, not recruitingNot applicable

First-Line Diagnostic Investigations for Suspected Adult Asthma

Asthma (Diagnosis)Condition

Spirometry, Fractional Exhaled Nitric OxideTreatment

United Kingdom1 locations

George Eliot HospitalSponsor

Updated 2026-08-28 · NCT07792213See eligibility →

Active, not recruitingNot applicable

Double Duty Interventions and Its Impact on Double Burden of Malnutrition in Children Under Five Years

Malnutrition, Malnutrition, ChildCondition

double duty intervention packagesTreatment

Ethiopia2 locations

Debre Berhan UniversitySponsor

Updated 2026-08-27 · NCT05791305See eligibility →

Active, not recruitingNot applicable

Inspiratory Muscle Strength Training in Adults With Obesity

ObesityCondition

High-resistance inspiratory muscle strength training, Very-low-resistance inspiratory muscle strength trainingTreatment

United States1 locations

Florida State UniversitySponsor

Updated 2026-08-27 · NCT05459636See eligibility →

Active, not recruitingPhase 1, Phase 2

A Trial to Learn How Safe AZD9550 Monotherapy and Combined With AZD6234 is in People With or Without Type 2 Diabetes Who Are Living With Obesity and Overweight

Overweight and ObesityCondition

AZD9550, placeboTreatment

Austria, Canada15 locations

AstraZenecaSponsor

Updated 2026-08-26 · NCT06151964See eligibility →

Active, not recruitingNot applicable

Influence of Obesity on Oxalate Metabolism and Handling in Calcium Oxalate Stone Formers

Kidney StoneCondition

Controlled Diet, Carbon-13 Oxalate and Sucralose IngestionTreatment

United States2 locations

University of Alabama at BirminghamSponsor

Updated 2026-08-26 · NCT04333745See eligibility →

Active, not recruitingNot applicable

Growing Healthy Children and Families in Rural Arkansas

Pediatric Obesity, Health Behavior, RiskyCondition

Growing Healthy Children and Families in Rural ArkansasTreatment

United States1 locations

University of ArkansasSponsor

Updated 2026-08-26 · NCT06565455See eligibility →

Active, not recruitingNot applicable

Time-Restricted Eating for Weight-Loss Maintenance

Overweight or Obese AdultsCondition

Scheduled Weight Maintenance Nutrition Education, Time-Restricted Eating (10-Hour Window)Treatment

China10 locations

Harbin Medical UniversitySponsor

Updated 2026-08-25 · NCT07163455See eligibility →

Active, not recruitingNot applicable

Postprandial Nutrient Homeostasis Before and After Weight Loss Induced by Low-calorie Diet or RYGB

ObesityCondition

Roux-en-Y gastric bypass surgery, Low-calorie dietTreatment

United States1 locations

Washington University School of MedicineSponsor

Updated 2026-08-25 · NCT03091725See eligibility →

Active, not recruitingNot applicable

Preventing Type 2 Diabetes in Black Emergent Adult

Type 2 Diabetes Mellitus, Binge-Eating DisorderCondition

Appetite Awareness Training (AAT), Diabetes Prevention Program (DPP)Treatment

United States1 locations

University of North Carolina, Chapel HillSponsor

Updated 2026-08-25 · NCT06848244See eligibility →

Active, not recruitingPhase 3

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Kidney Disease (CKD)Condition

Retatrutide, PlaceboTreatment

Argentina743 locations

Eli Lilly and CompanySponsor

Updated 2026-08-24 · NCT06383390See eligibility →

Active, not recruitingNot applicable

Intensive Weight Loss Intervention Versus Usual Care for Adults With Severe and Complex Obesity

ObesityCondition

Intensive weight loss intervention, Usual careTreatment

Denmark, United Kingdom14 locations

Carsten DirksenSponsor

Updated 2026-08-24 · NCT06321458See eligibility →

Active, not recruitingPhase 2

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

Overweight, Type 2 DiabetesCondition

Petrelintide, PlaceboTreatment

United States48 locations

Zealand PharmaSponsor

Updated 2026-08-21 · NCT06926842See eligibility →

Active, not recruitingPhase 4

A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity

Diabetes Mellitus, Type 2, ObesityCondition

TirzepatideTreatment

India21 locations

Eli Lilly and CompanySponsor

Updated 2026-08-21 · NCT07438444See eligibility →

Active, not recruitingNot applicable

Long Term Outcomes of Bariatric Patients Treated With Surgery or Endoscopy

GERD, ObesityCondition

Endoscopy, SurgeryTreatment

United States6 locations

Johns Hopkins UniversitySponsor

Updated 2026-08-21 · NCT03705416See eligibility →

Active, not recruitingPhase 1

Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes

Healthy Subjects, ObesityCondition

TLC-6740 Oral Solution, Placebo Oral SolutionTreatment

New Zealand4 locations

OrsoBio, IncSponsor

Updated 2026-08-21 · NCT05822544See eligibility →

Active, not recruitingNot applicable

BasketballRx: Game Changing Health

Pediatric Obesity, Pediatric OverweightCondition

BasketballRxTreatment

United States2 locations

Milton S. Hershey Medical CenterSponsor

Updated 2026-08-21 · NCT07778433See eligibility →

Active, not recruitingNot applicable

Fiber-rich Foods to Treat Obesity and Prevent Colon Cancer

Colon Cancer, ObesityCondition

High Fiber Diet Featuring Legumes (HLD), Healthy American DietTreatment

United States1 locations

Emory UniversitySponsor

Updated 2026-08-20 · NCT04780477See eligibility →

Active, not recruitingNot applicable

Investigating Metabolic and Psychological Adaptations in a Clinical Trial

Obesity and Type 2 DiabetesCondition

Behavioral Skill Training, Meal ProvisioningTreatment

United States1 locations

State University of New York at BuffaloSponsor

Updated 2026-08-19 · NCT06800794See eligibility →

Active, not recruitingEarly Phase 1

Optimization of Obesity for Total Knee Replacement With Glucagon-like Peptide-1 Receptor Agonist

Osteoarthritis (OA) of the KneeCondition

Glucagon-like peptide-1 receptor agonists (GLP 1 RA), Control (Standard treatment)Treatment

Hong Kong1 locations

The University of Hong KongSponsor

Updated 2026-08-19 · NCT06807970See eligibility →

Active, not recruitingPhase 1

A Study of LY4064912 in Healthy Participants and With Overweight or Obesity

Overweight or Obesity, HealthyCondition

LY4064912, LY4064912Treatment

Singapore, United States3 locations

Eli Lilly and CompanySponsor

Updated 2026-08-18 · NCT07152002See eligibility →

Active, not recruitingNot applicable

PA Moves Trial - Patient Participants

Overweight or Obesity, Diabetes Mellitus, Type 2Condition

Physical Activity, Delayed interventionTreatment

United States1 locations

University of PittsburghSponsor

Updated 2026-08-18 · NCT05227105See eligibility →

Active, not recruitingNot applicable

Delta GREENS Food is Medicine Intervention

Cardiometabolic Risk Factors, DiabetesCondition

Food is MedicineTreatment

United States1 locations

Tufts UniversitySponsor

Updated 2026-08-18 · NCT06358859See eligibility →

Active, not recruitingNot applicable

Weight Loss and Endocrine Disrupting Chemicals (EDCs): Lifestyle Interventions to Lose Weight and Reduce EDC Exposure in Individuals With Overweight/Obesity

Obesity &Amp;Amp;Amp; Overweight, Environmental ExposureCondition

Educational curriculum, Weight loss ApplicationTreatment

United States1 locations

Million Marker Wellness, Inc.Sponsor

Updated 2026-08-18 · NCT07560579See eligibility →

Active, not recruitingPhase 1

A Research Study on How NNC0638-0355, a New Medicine, Works in People Living With Overweight or Obesity

Obesity, OverweightCondition

NNC0638-0355, Placebo (NNC0638-0355)Treatment

Netherlands, United States4 locations

Novo Nordisk A/SSponsor

Updated 2026-08-17 · NCT06577766See eligibility →

Active, not recruitingNot applicable

Dietary Insights and Nutritional Education in Adults on GLP-1 Therapy

Obesity Type 2 Diabetes Mellitus, ObesityCondition

SWITCH Diets - Mobile Nutrition Behavioral InterventionTreatment

United States1 locations

University of South CarolinaSponsor

Updated 2026-08-17 · NCT07518407See eligibility →

This page shows the first 60 studies. Use the full search to filter all matches.

Related statuses

Recruiting now1,541 Opening soon671 Invitation only133

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.